Newsroom

Drug pricing will continue to loom large in 2016

Of all the health care issues that loomed large this past year, none was more controversial — and compelling — than pharmaceutical pricing. Wall Street may have cheered the added revenue, but pricing strategies were increasingly under attack. Poll after poll found most Americans believe prices are too high. And more lawmakers — and presidential candidates — are listening.

Read more

CMS Introduces Medicare Drug Spending Dashboard

This afternoon, the Centers for Medicare & Medicaid Services took an important step in the drug pricing conversation by introducing a tool that will increase transparency. To develop realistic market-based solutions to unsustainable drug prices requires that everyone focus on value and transparency in drug pricing, and this latest effort from CMS is a positive step.”

Read more

Prime Therapeutics Joins the Campaign for Sustainable Rx Pricing

Prime Therapeutics LLC (Prime), an independent pharmacy benefit manager overseeing pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid, recently joined the Campaign for Sustainable Rx Pricing (CSRxP). The coalition is a broad-based organization committed to raising awareness about high drug prices and advancing positive, market-oriented solutions to the affordability crisis caused by escalating drug prices.

Read more

Rx Pricing – A Year in Review

Drug pricing has been a hot topic in 2015 — and what a year it has been! As the year winds down, we wanted to revisit a […]

Read more